Cryopreserved mesenchymal stromal cells display impaired immunosuppressive properties as a result of heat-shock response and impaired interferon-γ licensing

Cytotherapy

Volumn 14, Issue 2, 2012, Pages 147-152

  François, Mora ^a,b   Copland, Ian B ^c   Yuan, Shala ^b   Romieu Mourez, Raphalle ^b   Waller, Edmund K ^c   Galipeau, Jacques ^b,c  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c EMORY UNIVERSITY   (United States)

Author keywords

Cryopreservation; Immunosuppression; Immunotherapy; Indoleamine 2,3 dioxygenase; Interferon gamma; Mesenchymal stromal cells

Indexed keywords

CD28 ANTIGEN; GAMMA INTERFERON; INDOLEAMINE 2,3 DIOXYGENASE;

ARTICLE; CD3+ T LYMPHOCYTE; CELL PROLIFERATION; CRYOPRESERVATION; HEAT SHOCK RESPONSE; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; MESENCHYME CELL; PRIORITY JOURNAL; STROMA CELL; T LYMPHOCYTE; THAWING; UPREGULATION;

EID: 84855890176     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.3109/14653249.2011.623691     Document Type: Article

References (18)

1. Meisel R, Zibert A, Laryea M, Gobel U, Daubener W, Dilloo D. Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryp-tophan degradation. Blood. 2004;103:4619-21. (Pubitemid 38745993)
2. Ren G, Su J, Zhang L, Zhao X, Ling W, L'Huillie A, et al. Species variation in the mechanisms of mesenchymal stem cell-mediated immunosuppression. Stem Cells. 2009;27: 1954-62.
3. Koc ON, Gerson SL, Cooper BW, Dyhouse SM, Haynesworth SE, Caplan AI, et al. Rapid hematopoietic recovery after coin-fusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J Clin Oncol. 2000;18:307-16. (Pubitemid 30056419)
4. Le BK, Frassoni F, Ball L, Locatelli F, Roelofs H, Lewis I, et al. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: A phase II study. Lancet. 2008;371:1579-86. (Pubitemid 351626841)
5. Ringden O, Uzunel M, Rasmusson I, Remberger M, Sundberg B, Lonnies H, et al. Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplantation. 2006;81:1390-7. (Pubitemid 43847148)
6. von BM, Stolzel F, Goedecke A, Richter K, Wuschek N, Holig K, et al. Treatment of refractory acute GVHD with third-party MSC expanded in platelet lysate-containing medium. Bone Marrow Transplant. 2009;43:245-51.
7. Le BK, Frassoni F, Ball L, Locatelli F, Roelofs H, Lewis I, et al. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: A phase II study. Lancet. 2008;371:1579-86. (Pubitemid 351626841)
8. Allison M. Genzyme backs Osiris, despite prochymal fl op. Nat Biotechnol. 2009;27:966-7.
9. Colter DC, Sekiya I, Prockop DJ. Identification of a subpopulation of rapidly self-renewing and multipotential adult stem cells in colonies of human marrow stromal cells. Proc Natl Acad Sci USA. 2001;98:7841-5. (Pubitemid 32642648)
10. Romieu-Mourez R, Francois M, Boivin MN, Stagg J, Gali-peau J. Regulation of MHC class II expression and antigen processing in murine and human mesenchymal stromal cells by IFN-gamma, TGF-beta, and cell density. J Immunol. 2007;179:1549-58.
11. Romieu-Mourez R, Francois M, Boivin MN, Bouchentouf M, Spaner DE, Galipeau J. Cytokine modulation of TLR expression and activation in mesenchymal stromal cells leads to a proinfl ammatory phenotype. J Immunol. 2009;182: 7963-73.
12. Liu K, Yang Y, Mansbridge J. Comparison of the stress response to cryopreservation in monolayer and three-dimensional human fibroblast cultures: stress proteins, MAP kinases, and growth factor gene expression. Tissue Eng. 2000;6: 539-54.
13. Cuesta R, Laroia G, Schneider RJ. Chaperone Hsp27 inhibits translation during heat shock by binding eIF4G and facilitating dissociation of cap-initiation complexes. Genes Dev. 2000;14:1460-70. (Pubitemid 30421839)
14. Kedersha N, Anderson P. Stress granules: sites of mRNA triage that regulate mRNA stability and translatability. Bio-chem Soc Trans. 2002;30:963-9. (Pubitemid 36002389)
15. Kenis H, Zandbergen HR, Hofstra L, Petrov AD, Dumont EA, Blankenberg FD, et al. Annexin A5 uptake in ischemic myocardium: demonstration of reversible phosphatidylserine externalization and feasibility of radionuclide imaging. J Nucl Med. 2010;51:259-67.
16. van den Eijnde SM, van den Hoff MJ, Reutelingsperger CP, van Heerde WL, Henfl ing ME, Vermeij-Keers C, et al. Transient expression of phosphatidylserine at cell-cell contact areas is required for myotube formation. J Cell Sci. 2001;114:3631-42. (Pubitemid 33041045)
17. Fadeel B, Xue D, Kagan V. Programmed cell clearance: molecular regulation of the elimination of apoptotic cell corpses and its role in the resolution of infl ammation. Bio-chem Biophys Res Commun. 2010;396:7-10.
18. Li MO, Sarkisian MR, Mehal WZ, Rakic P, Flavell RA. Phos-phatidylserine receptor is required for clearance of apoptotic cells. Science. 2003;302:1560-3. (Pubitemid 37475698)